| Wang Zhenyi | |||||
| Birth Date: | 30 November 1924 | ||||
| Birth Place: | Xinghua, Jiangsu, China | ||||
| Fields: | Pathophysiology Hematology | ||||
| Workplaces: | Shanghai Jiao Tong University School of Medicine | ||||
| Alma Mater: | Aurora University Columbia University | ||||
| Thesis1 Title: | and | ||||
| Thesis2 Title: | )--> | ||||
| Thesis1 Url: | and | ||||
| Thesis2 Url: | )--> | ||||
| Thesis1 Year: | and | ||||
| Thesis2 Year: | )--> | ||||
| Doctoral Advisors: | )--> | ||||
| Module: |
| ||||
Wang Zhenyi (; born November 30, 1924), also known as Zhen-yi Wang, is a Chinese pathophysiologist and hematologist who is a professor emeritus of Medicine and Pathophysiology at the Shanghai Jiao Tong University (SJTU). He is most well known for discovering the cure for acute promyelocytic leukemia while working with Laurent Degos in France, using tretinoin on a trial of 24 patients at Ruijin Hospital in 1986.
Wang was born in November 1924 in Shanghai, with his ancestral hometown in Yixing, Jiangsu Province. Wang graduated from the Aurora University in Shanghai in 1948 and obtained his M.D. degree.
From 1948 to 1960, Wang completed his residency and worked as a physician at Ruijin Hospital in Shanghai. From 1960 to 1982, Wang taught at Shanghai Second Medical University (now Medical School of Shanghai Jiao Tong University), and was the dean of its pathology and physiology departments. From 1982 to 1984, Wang was the director of the Division of Basic Medicine of Shanghai Second Medical University. From 1984 to 1988, Wang was the president of Shanghai Second Medical University. From 1987 to 1996, Wang was the Director of Shanghai Institute of Hematology (SIH). Wang now is the Honorary Director of SIH.
Wang's research has led to the improved survival of patients with acute promyelocytic leukemia (APML). Wang is the author of more than 300 scientific papers and books.
Chen Zhu (former Minister of Health of China) and his wife Chen Saijuan are both hematologists and former students of Wang.
Wang is also a member of the Chinese Society of Pathophysiology, and the International Society of Fibrinolysis.